Company Filing History:
Years Active: 1995-2000
Title: The Innovations of Hans-Peter Schubert
Introduction
Hans-Peter Schubert is a notable inventor based in Apfeldorf, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of dementia and nerve damage. With a total of 3 patents to his name, Schubert's work reflects a commitment to advancing medical science.
Latest Patents
One of Schubert's latest patents is a combination preparation for use in dementia. This invention relates to a pharmaceutical combination that includes a compound with acetylcholinesterase-inhibitory action or muscarinergic action, along with a compound that increases the endogenous extracellular adenosine level. This combination is designed for the treatment of dementia and includes a process for its production and application in patient therapy. Another significant patent involves the use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery. This patent discloses the use of this compound, or its physiologically tolerated salts, for preparing pharmaceuticals aimed at preventing and treating nerve damage following blood circulation interruption.
Career Highlights
Hans-Peter Schubert is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work at Hoechst has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Throughout his career, Schubert has collaborated with notable colleagues, including John J. Grome and Karl Rudolphi. These partnerships have contributed to the development of his innovative patents and advancements in medical treatments.
Conclusion
Hans-Peter Schubert's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare outcomes. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions.